Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 901 AL 915

Case report: a giant arachnoid cyst masking Alzheimer's disease

Wahl AS, Löffler M, Hausner L, Ruttorf M, Nees F, Frölich L.

BMC Psychiatry. 2019 Sep 5;19(1):274. doi: 10.1186/s12888-019-2247-8.

Cerebral changes improved by physical activity during cognitive decline: A systematic review on MRI studies

Haeger A, Costa AS, Schulz JB, Reetz K.

Neuroimage Clin. 2019;23:101933. doi: 10.1016/j.nicl.2019.101933. Epub 2019 Jul 16.

Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial

Schneider LS, Geffen Y, Rabinowitz J, Thomas RG, Schmidt R, Ropele S, Weinstock M; Ladostigil Study Group.

Neurology. 2019 Oct 8;93(15):e1474-e1484. doi: 10.1212/WNL.0000000000008239. Epub 2019 Sep 6.

Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review

Huq AJ, Fransquet P, Laws SM, Ryan J, Sebra R, Masters CL, Winship IM, James PA, Lacaze P.

Alzheimers Dement. 2019 Dec;15(12):1612-1623. doi: 10.1016/j.jalz.2019.05.011. Epub 2019 Sep 7.

Extra-virgin olive oil for potential prevention of Alzheimer disease

Román GC, Jackson RE, Reis J, Román AN, Toledo JB, Toledo E.

Rev Neurol (Paris). 2019 Dec;175(10):705-723. doi: 10.1016/j.neurol.2019.07.017. Epub 2019 Sep 11.

The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease

Randolph C.

Am J Geriatr Psychiatry. 2019 Dec;27(12):1428-1432. doi: 10.1016/j.jagp.2019.08.012. Epub 2019 Aug 19.

Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder

Lu H, Chan SSM, Chan WC, Lin C, Cheng CPW, Linda Chiu Wa L.

Ann Clin Transl Neurol. 2019 Oct;6(10):1938-1948. doi: 10.1002/acn3.50823. Epub 2019 Sep 17.

Molecular Links Between Alzheimer's Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection Involvement

Katsinelos T, Doulberis M, Polyzos SA, Papaefthymiou A, Katsinelos P, Kountouras J.

Curr Mol Med. 2019;20(1):3-12. doi: 10.2174/1566524019666190917125917.

Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer's Disease

Paudel YN, Angelopoulou E, Jones NC, O'Brien TJ, Kwan P, Piperi C, Othman I, Shaikh MF.

ACS Chem Neurosci. 2019 Oct 16;10(10):4199-4212. doi: 10.1021/acschemneuro.9b00460. Epub 2019 Sep 30.

Time to test antibacterial therapy in Alzheimer's disease

Panza F, Lozupone M, Solfrizzi V, Watling M, Imbimbo BP.

Brain. 2019 Oct 1;142(10):2905-2929. doi: 10.1093/brain/awz244.

Is Toxoplasma gondii a potential risk factor for Alzheimer's disease? A systematic review and meta-analysis

Nayeri Chegeni T, Sarvi S, Moosazadeh M, Sharif M, Aghayan SA, Amouei A, Hosseininejad Z, Daryani A.

Microb Pathog. 2019 Dec;137:103751. doi: 10.1016/j.micpath.2019.103751. Epub 2019 Sep 16.

Risk factors for Alzheimer's disease

A Armstrong R.

Folia Neuropathol. 2019;57(2):87-105. doi: 10.5114/fn.2019.85929.

Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images

Gupta Y, Lee KH, Choi KY, Lee JJ, Kim BC, Kwon GR; National Research Center for Dementia; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2019 Oct 4;14(10):e0222446. doi: 10.1371/journal.pone.0222446. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias